Skip to main content

Table 1 Study Characteristics a

From: Ideal vs. real: a systematic review on handling covariates in randomized controlled trials

Study Characteristic

 

Overall

2009

2014

p-value b

Type of Study

Superiority

255 (86)

110 (84)

145 (87)

0.3047

Non-Inferiority

23 (8)

9 (7)

14 (8)

 

Other

20 (7)

12 (9)

8 (5)

 

Cluster-Randomized

No

277 (93)

117 (89)

160 (96)

0.0297

Yes

21 (7)

14 (11)

7 (4)

 

Number of Arms

2

236 (79)

107 (82)

129 (77)

0.5970

3

24 (8)

8 (6)

16 (10)

 

4

26 (9)

12 (9)

14 (8)

 

5 or more

12 (4)

4 (3)

8 (5)

 

Multicenter Study

Single Center

24 (8)

15 (11)

9 (5)

0.0563

Multicenter

274 (92)

116 (89)

158 (95)

 

Number of Centers

 

22 (5–71)

20 (4–68)

24 (6–76)

0.6291

Number of Subjects

 

556 (242–1408)

700 (279–1888)

457 (222–1224)

0.0770

Length of Study, Years (if reported)

 

3 (2–5)

3 (2–5)

3 (2–5)

0.6667

Months of Subject Follow-up (if reported)

 

12 (4–20)

12 (4–22)

12 (4–19)

0.8274

Study Initiation Year

Before 2000

17 (6)

13 (10)

4 (2)

<.0001

2004–2005

75 (26)

66 (52)

9 (5)

 

2005–2009

123 (42)

48 (38)

75 (45)

 

2010 and later

78 (27)

0 (0)

78 (47)

 

Primary Outcome

Continuous

89 (30)

42 (32)

47 (28)

0.2663

Binary

113 (38)

42 (32)

71 (43)

 

Time-to-Event

84 (28)

40 (31)

44 (26)

 

Other

12 (4)

7 (5)

5 (3)

 

Randomization Indicated in Title

No

94 (32)

40 (31)

54 (32)

0.7398

Yes

204 (68)

91 (69)

113 (68)

 

Allocation Method

Purely random allocation

4 (1)

3 (2)

1 (1)

0.1660

Blocked (Permuted or Random block)

24 (8)

9 (7)

15 (9)

 

Stratified or Stratified block

205 (69)

82 (63)

123 (74)

 

Minimization/Covariate-adaptive method

32 (11)

18 (14)

14 (8)

 

Other

4 (1)

2 (2)

2 (1)

 

Unable to determine

29 (10)

17 (13)

12 (7)

 

Covariate(s) Included in Allocation

No

27 (9)

12 (9)

15 (9)

0.3278

Yes

241 (81)

102 (78)

139 (83)

 

Unable to determine

30 (10)

17 (13)

13 (8)

 

Number of Covariates

1

95 (39)

42 (41)

53 (38)

0.5106

2

86 (36)

32 (31)

54 (39)

 

3

40 (17)

17 (17)

23 (17)

 

4

11 (5)

5 (5)

6 (4)

 

5 or more

9 (4)

6 (6)

3 (2)

 

Baseline Test for Significant Differences

No

167 (57)

76 (59)

91 (55)

0.5564

Yes

126 (43)

53 (41)

73 (45)

 

Unadjusted or Adjusted Analyses

Unadjusted

49 (16)

27 (21)

22 (13)

0.0100

Adjusted

87 (29)

27 (21)

60 (36)

 

Both

162 (54)

77 (59)

85 (51)

 

Reason for Adjustment (if applicable)

Pre-specified

226 (91)

88 (85)

138 (95)

0.0778c

Data driven - Lack of balance

5 (2)

3 (3)

2 (1)

 

Data driven - Potential confounding

6 (2)

4 (4)

2 (1)

 

Other

4 (2)

3 (3)

1 (1)

 

Unable to determine

8 (3)

6 (6)

2 (1)

 
  1. aPercentages were calculated based on non-missing values
  2. bP-value corresponds to chi-squared test result or Wilcoxon Rank-Sum test result for comparison of study characteristics by publication year, as appropriate
  3. cWithin the subset of trials reporting adjusted analyses, 95% of trials from 2014 vs. 85% of those from 2009 pre-specified adjustments (p = 0.0045)